Global Home Infusion Therapy Market Size research report 2022 offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market.
The global home infusion therapy market size was valued at USD 27.25 billion in 2019 and is projected to reach USD 86.89 billion by 2027, exhibiting a CAGR of 2.2% during the forecast period.
Drivers & Restraints
The implementation of regulations by the Centers for Medicare & Medicaid Services (CMC), has waived off the need for nurses and physicians to visit patients at home and have directed the visits to be held via Telehealth platforms. The virtual patient handling offers certain drawbacks as it becomes difficult for caregivers to obtain import data through a video call. This is anticipated to slightly hinder the uptake of infusion therapy at home, especially among hospitalized patients. However, initiatives taken by various governments for the development of new reimbursement policies, providing cost-effective infusion products & services to the patients at home are likely to pose a positive impact on the market during coronavirus pandemic.
This study provides information about the sales and revenue during the historic and forecasted period of (2022 to 2028). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Home Infusion Therapy Market report.
This report focuses on Home Infusion Therapy Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Home Infusion Therapy Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa.
One of the most common uses for infusion therapy is to treat chronic pain. Infusions of prednisone or other medications can effectively manage persistent pain, reducing its severity and preventing it from returning. In addition, infusion therapy can be used to treat conditions like multiple sclerosis, rheumatoid arthritis, and Crohn’s disease.
Also check: Neuropathy no more reviews
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
An Overview of the Impact of COVID-19 on this Market:
The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic.
We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what’s to come.
iritis Health Atlanta offers therapy management services and treatments for patients with autoimmune disorders, including chronic inflammatory demyelinating polyneuropathy, multiple sclerosis and myasthenia gravis. The AIC also provides treatments for and manages patients with various inflammatory conditions, such as thyroid eye disease, Crohn’s disease, rheumatoid arthritis, ulcerative colitis, as well as primary immunodeficiencies and rare and ultra-rare diseases.
One of the reasons for this growth in home infusion therapy market is that they are more cost-effective than traditional treatments. For example, a single dose of antibiotics purchased in a pharmacy can cost $40-$60, while a single dose of antibiotics purchased through a home infusion pharmacy can cost around $10-$20. Additionally, many home infusion therapies are safe and easy to use, making them ideal for patients who do not have access to health care or who wish to take their treatment at home.
In addition, the rising prevalence of chronic diseases, such as cardiovascular diseases (CVDs), cancer, diabetes, and other life-threatening conditions, is expected to have a high impact on the market growth. According to a WHO report, the above-mentioned diseases accounted for 60.0% of the total deaths and 43.0% of the disease burden in the U.S. in 2022. This creates the need to infuse nutritional products that contain glutamine, phospholipids, glucose, and amino acids while administering medication to patients, which, in turn, is expected to boost the market growth in this region.
Key players covered in the global Home Infusion Therapy Market research report:
- Option Care Health Inc. (Illinois, U.S.)
- Optum, Inc. (Minnesota, U.S.)
- CareCentrix, Inc. (Hartford, U.S.)
- Lincare Holdings Inc. (Florida, U.S.)
- BriovaRx Infusion Services (Houston, U.S.)
- Fresenius SE & Co. KGaA (Bad Homburg, Germany)
- Baxter International (Deerfield, Illinois, U.S.)
- B. Braun Melsungen AG (Melsungen, Germany)
- Terumo Corporation (Tokyo, Japan)
- Moog Inc. (New York, U.S.)
Market Share Analysis:
The Market Also, share Analysis offers the analysis of vendors considering their contribution to the overall market. It May provide the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
PCA is increasingly, commonly used in the home setting as an effective option for pain management. Previously, the subcutaneous and intravenous routes are the primary methods of administration. likewise, the safety and efficacy of PCA opioid therapy has been extensively reported. The use of morphine PCA in the home environment was both safe and effective in the home environment, attaining excellent results in 66% patients and satisfactory pain relief in 30%.
PCA was considered insufficient in 4% of cases. Side effects, in general, were considered mild: the most common being constipation, fatigue, and nausea. The experience of the authors is similar with home PCA.
Over measurement of drugs might cause dangerous circumstances, absence of gifted attendants in the creating and immature locale, abnormality in the working of infusion gadgets and misinformed utilization of imbuement gadgets which might block the development of this market.
- Natural substance providers
- Administrative bodies, including government organizations and NGO
- Business innovative work (RandD) establishments
- Merchants and exporters
- Government associations, research associations, and counseling firms
- Exchange affiliations and industry bodies
- End-use enterprises
Major Table of Contents for Home Infusion Therapy Market Research Report:
- Executive Summary
- Market Dynamics
- Key Market Growth Insights
- Global Market Analysis, Insights and Forecast, 2017-2028
- North America Market Analysis, Insights and Forecast, 2017-2028
- Europe Market Analysis, Insights and Forecast, 2017-2028
- Asia Pacific Market Analysis, Insights and Forecast, 2017-2028
- The Middle East and Africa Market Analysis, Insights and Forecast, 2017-2028
- Latin America Market Analysis, Insights and Forecast, 2017-2028
- Competitive Landscape
- Global Home Infusion Therapy Market Revenue Growth, Industry Share Analysis, By Key Players, 2021
- Company Profiles
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245